IRIS

Percentage of prostate-specific antigen reduction is a useful tool to assess men following focal therapy for localised prostate cancer.

The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series

Stabile A.;Montorsi F.;Briganti A.;
2020-01-01

Abstract

Percentage of prostate-specific antigen reduction is a useful tool to assess men following focal therapy for localised prostate cancer.
2020
Inglese
Elsevier B.V.
78
2
155
160
6
Epub ahead of print
2-s2.0-85084828369
WOS:000551280300024
Focal therapy
High-intensity focused ultrasound
Minimally invasive therapy
Outcome
Prostate cancer
Therapy
Sì
none
14
info:eu-repo/semantics/article
262
Stabile, A.; Orczyk, C.; Giganti, F.; Moschini, M.; Allen, C.; Punwani, S.; Cathala, N.; Ahmed, H. U.; Cathelineau, X.; Montorsi, F.; Emberton, M.; Br...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/108656
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 29
social impact